BridgeMD
New treatment option for Psoriatic Arthritis
Official title A Study to Learn if Bimekizumab Given in Different Ways is Safe and Moves Similarly Throughout the Body Over Time in Adults
ClinicalTrials.gov ID: NCT07290036
What this study is testing
What is Bimekizumab regimen 1 iv?
Bimekizumab regimen 1 iv is an investigational medicine, given as an injection under the skin, being studied as a potential treatment for psoriatic arthritis.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- To demonstrate that bimekizumab administered intravenously is noninferior to subcutaneous administration.
- Phase 1: an early, usually small safety study
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Be 18+ years old and legally able to consent
- Have active psoriatic arthritis (PsA) or axial spondyloarthritis (axSpA), suitable for bimekizumab treatment
- Weigh between 45-100 kg (females) or 50-100 kg (males).
- Be biologic disease-modifying anti-rheumatic drug (bDMARD)-naïve or have stopped bDMARDs ≥3 months or 5 half-lives ago
You likely can't join if
- Serious organ system disorders (e.g., heart, liver, kidney, gastrointestinal, neuro)
- Severe psychiatric issues or substance abuse in the past year
- Recent or chronic infections, including tuberculosis (TB) or nontuberculous mycobacterium (NTMB)
- Other inflammatory diseases (e.g., rheumatoid arthritis (RA), lupus, inflammatory bowel disease (IBD))
- Recent live vaccines (within 8 weeks) or Bacillus Calmette-Guerin (BCG) (within 1 year)
- Recent use of glucagon-like peptide-1 (GLP-1) agonists (within 28 weeks)
The study team makes the final eligibility decision.
Where it's taking place
- Peoria, Arizona, United States
- Apple Valley, California, United States
- Covina, California, United States
- Fullerton, California, United States
- Riverside, California, United States
- San Leandro, California, United States
- Temecula, California, United States
- Upland, California, United States
- Whittier, California, United States
- Fort Collins, Colorado, United States
- Ormond Beach, Florida, United States
- South Miami, Florida, United States
- Zephyrhills, Florida, United States
- Chicago, Illinois, United States
- Lansing, Michigan, United States
- West Long Branch, New Jersey, United States
- Albuquerque, New Mexico, United States
- Vandalia, Ohio, United States
- Duncansville, Pennsylvania, United States
- Rock Hill, South Carolina, United States
+ 35 more site(s).
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Peoria, Arizona, United States; Apple Valley, California, United States; Covina, California, United States; Fullerton, California, United States; Riverside, California, United States; San Leandro, California, United States and 49 more location(s). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.